Nautilus Biotechnology Inc. (NAUT) Live Share Price, Invest From India

Nautilus Biotechnology Inc. Stock Performance

as on July 25, 2026 at 2:15 pm IST

Day's Low
Day's High
$1.68
Day's Price Range
$1.79
$1.69
0.59%
Downside
5.92%
Upside
52 Week's Low
52 Week's High
$0.62
52-Week Price Range
$4.31
$1.69
63.31%
Downside
155.04%
Upside

Nautilus Biotechnology Inc. share price movements today

Previous Close: $1.77
Open: $1.77
Volume: 1.5M
Day's Low - High: $1.68 - $1.79
52 Week Low - High: $0.62 - $4.31

Nautilus Biotechnology Inc. Historical Returns

1 Month Return: -15.5 %
3 Month Return: -35.5 %
1 Year Return: + 122.98 %
3 Year Return: -45.48 %
5 Year Return: -80.35 %

Nautilus Biotechnology Inc. Stock Fundamentals & Key Indicators

Check Nautilus Biotechnology Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$224.9M

EPS (TTM)

-0.515

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-62.5M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-33.69%

Nautilus Biotechnology Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Nautilus Biotechnology Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Nautilus Biotechnology Inc.	BUY	$224.9M	-80.35%	NA	0.00%	NA
Revolution Medicines Inc.	BUY	$40.1B	576.3%	NA	0.00%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.1B	139.96%	28.01	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$68.3B	13.54%	15.9	29.65%	0.5499999999999999%

Stock Returns calculator for Nautilus Biotechnology Inc. Stock including INR - Dollar returns

The Nautilus Biotechnology Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Nautilus Biotechnology Inc. investment value today

Current value as on today

₹2,48,223

Returns

₹1,48,223

(+148.22%)

Returns from Nautilus Biotechnology Inc. Stock

₹1,22,368 (+122.37%)

Dollar Impact

₹25,854 (+25.85%)

Analyst Recommendation on Nautilus Biotechnology Inc. Stock

Based on 10 analysts

BUY

70.00%

Buy

30.00%

Hold

0.00%

Sell

Based on 10 analysts, 70% of analysts recommend a 'BUY' rating for Nautilus Biotechnology Inc.. Average target price of $4

Nautilus Biotechnology Inc. Share Price Target

Get share price movements and forecasts by analysts on Nautilus Biotechnology Inc..

What analysts predicted

57.75%UPSIDE

Target Price

Current Price

$1.69

Analyzed by

10 Analysts

Target

$4.00

Nautilus Biotechnology Inc. target price $4, a slight upside of 57.75% compared to current price of $1.69. According to 10 analysts rating.

Indian Investors' Interest in Nautilus Biotechnology Inc. Stock

Search interest for Nautilus Biotechnology Inc. Stock has increased by 131% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 26, 2026 to July 26, 2026

Change:131% versus previous 30 day period

Nautilus Biotechnology Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	8	-	-	-	9	-	-	-	-	-
Gross Profit	-1	-1	-1	-1	-6	-1	-1	-1	-1	-1
Operating Income	-20	-21	-20	-19	-19	-18	-17	-15	-15	-16
EBITDA	-15	-17	-16	-14	-11	-14	-13	-11	-12	-13
Interest Expense	3	-	-	-	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	1	1	1
Income Before Tax	-17	-18	-18	-16	-17	-16	-15	-13	-13	-14
Income Tax Expense	-3	1	-	1	-	-	-	-	-	-
Net Income	-17	-18	-18	-16	-17	-16	-15	-13	-13	-14
Net Profit Margin	-207.31%	0.00%	0.00%	0.00%	-183.27%	0.00%	0.00%	0.00%	0.00%	0.00%

Nautilus Biotechnology Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-
Gross Profit	-2	-2	-3	-5	-6	-6
Operating Income	-15	-50	-63	-76	-81	-66
EBITDA	-13	-47	-54	-61	-64	-52
Interest Expense	-	0	5	-	-	-
Depreciation	2	2	3	5	6	6
Income Before Tax	-15	-50	-57	-63	-70	-59
Income Tax Expense	2	2	5	-	-70	-
Net Income	-15	-50	-57	-63	-70	-59
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Nautilus Biotechnology Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-18	-18	-16	-17	-16	-15	-13	-13	-14
Operating Cash Flow	-16	-15	-13	-14	-13	-13	-11	-12	-13
Investing Cash Flow	22	14	-7	37	19	14	0	0	14
Financing Cash Flow	0	0	0	0	0	0	-	0	1
Change in Cash	6	0	-20	23	5	1	-10	-11	2

Nautilus Biotechnology Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-15	-50	-57	-63	-70	-59
Operating Cash Flow	-9	-13	-39	-45	-51	-59	-50
Investing Cash Flow	4	-25	-138	-25	-43	66	35
Financing Cash Flow	0	75	327	0	0	1	0
Change in Cash	0	36	149	-70	-95	8	-15

Global Institutional Holdings in Nautilus Biotechnology Inc.

Funds	Holdings
Madrona Venture Group, LLC	4.74%
Hartland & Co	1.83%
Clarius Group, LLC	0.95%
Perceptive Advisors LLC	9.91%
Crewe Advisors LLC	0.11%

See all

Insights on Nautilus Biotechnology Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Revolution Medicines, Inc. Common Stock has given 634.9% return, outperforming this stock by 681.2%
NO EFFECT
Against Peers
In the last 1 year, Revolution Medicines, Inc. Common Stock has given 399.2% return, outperforming this stock by 276.2%
NEGATIVE IMPACT
Price Dip
In the last 1 month, NAUT stock has moved down by -25.6%

About Nautilus Biotechnology Inc.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In addition, the company offers single-molecule library preparation kits, flow cells, affinity reagents, and instrument run buffers to perform multi-cycle analysis runs. It has a research collaboration agreement Genentech, Buck Institute, Allen Institute, Cornell University and the Qatar Foundation, and Michael J. Fox Foundation. Nautilus Biotechnology, Inc. was founded in 2016 and is headquartered in Seattle, Washington.

Organisation	Nautilus Biotechnology Inc.
Headquarters	2701 Eastlake Avenue East, Seattle, WA, United States, 98102
Industry	Biotechnology
CEO	Mr. Sujal M. Patel
E-voting on shares	Click here to vote

Key Management of Nautilus Biotechnology Inc.

Name	Title
Ms. Gwen E. Weld	Chief People Officer
Dr. Subra Sankar Ph.D.	Senior Vice President of Product Development
Mr. Sujal M. Patel	Co-Founder, CEO, President, Secretary & Director
Dr. Parag Mallick Ph.D.	Co-Founder, Chief Scientist & Director
Ms. Anna Mowry	CFO & Treasurer
Mr. Matthew B. Murphy ESQ.	General Counsel
Ms. Amber Faust	Vice President of Global Sales
Ms. Jamie Rose Kuhar Ph.D.	Vice President of Marketing

FAQs

What is Nautilus Biotechnology Inc. share price today?

Nautilus Biotechnology Inc. share price today is $1.69 as on July 25, 2026 at 8:45 am IST at the close of the market. Nautilus Biotechnology Inc. share today touched a day high of $1.79 and a low of $1.68.

What is the 52 week high and 52 week low for Nautilus Biotechnology Inc. share?

Nautilus Biotechnology Inc. share touched a 52 week high of $4.31 on March 25, 2026 and a 52 week low of $0.62 on September 4, 2025. Nautilus Biotechnology Inc. stock price today i.e. July 25, 2026 at 8:45 am IST is closed at $1.69,which is 60.79% down from its 52 week high and 172.58% up from its 52 week low.

What is Nautilus Biotechnology Inc.'s market capitalisation today?

Nautilus Biotechnology Inc. market capitalisation is $0.00T as on July 25, 2026 at 8:45 am IST.

How to invest in Nautilus Biotechnology Inc. Stock (NAUT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Nautilus Biotechnology Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Nautilus Biotechnology Inc. Shares that will get you 0.8876 shares as per Nautilus Biotechnology Inc. share price of $1.69 per share as on July 25, 2026 at 8:45 am IST.

What is the minimum amount required to buy Nautilus Biotechnology Inc. Stock (NAUT) from India?

Indian investors can start investing in Nautilus Biotechnology Inc. (NAUT) shares with as little as ₹96.56 or $1 (as of July 26, 2026 at 4:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹965.60 in Nautilus Biotechnology Inc. stock (as per the Rupee-Dollar exchange rate as on July 26, 2026 at 4:39 am IST). Based on Nautilus Biotechnology Inc. share’s latest price of $1.69 as on July 25, 2026 at 8:45 am IST, you will get 5.9172 shares of Nautilus Biotechnology Inc.. Learn more about fractional shares .

What are the returns that Nautilus Biotechnology Inc. has given to Indian investors in the last 5 years?

Nautilus Biotechnology Inc. stock has given -80.35% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?